AORT
Price
$20.09Alerts
Change
-$0.38 (-1.86%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
985.36M
98 days until earnings call
Intraday BUY SELL Signals
SRTS
Price
$3.41Alerts
Change
+$0.11 (+3.33%)
Updated
Nov 11 closing price
Capitalization
47.08M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

AORT vs SRTS

AORT vs SRTS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AORT vs. SRTS commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Hold and SRTS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AORT with price predictions
Nov 11, 2026

AORT in +12.17% Uptrend, advancing for three consecutive days on November 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AORT advanced for three days, in 221 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

AORT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for AORT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 23 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AORT as a result. In 51 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.

The Moving Average Convergence Divergence Histogram (MACD) for AORT turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 33 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.

AORT moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AORT crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for AORT entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.211) is normal, around the industry mean (4.142). AORT's P/E Ratio (-404.200) is considerably lower than the industry average of (3.291). Projected Growth (PEG Ratio) (4.200) is also within normal values, averaging (11.253). Dividend Yield (0.006) settles around the average of (0.011) among similar stocks. P/S Ratio (2.603) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. AORT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AORT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SRTS with price predictions
Nov 11, 2026

SRTS in downward trend: price may decline as a result of having broken its higher Bollinger Band on November 03, 2026

SRTS broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 45 similar instances where the stock broke above the upper band. In 41 of the 45 cases the stock fell afterwards. This puts the odds of success at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SRTS moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 27 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for SRTS entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on SRTS as a result. In 79 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for SRTS just turned positive on November 03, 2026. Looking at past instances where SRTS's MACD turned positive, the stock continued to rise in 35 of 39 cases over the following month. The odds of a continued upward trend are 90%.

SRTS moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SRTS crossed bullishly above the 50-day moving average on November 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Following a +7.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTS advanced for three days, in 222 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.277) is normal, around the industry mean (4.142). P/E Ratio (-3.043) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.874) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. SRTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
AORT vs SRTS: Fundamental Ratings
AORT
SRTS
OUTLOOK RATING
1..100
1296
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9197
PRICE GROWTH RATING
1..100
7450
P/E GROWTH RATING
1..100
9934
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AORT's Valuation (3) in the Medical Specialties industry is in the same range as SRTS (27). This means that AORT’s stock grew similarly to SRTS’s over the last 12 months.

AORT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRTS (100). This means that AORT’s stock grew similarly to SRTS’s over the last 12 months.

AORT's SMR Rating (91) in the Medical Specialties industry is in the same range as SRTS (97). This means that AORT’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's Price Growth Rating (50) in the Medical Specialties industry is in the same range as AORT (74). This means that SRTS’s stock grew similarly to AORT’s over the last 12 months.

SRTS's P/E Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for AORT (99). This means that SRTS’s stock grew somewhat faster than AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTSRTS
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
73%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
81%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (AORT: $20.10 vs. SRTS: $3.30)
Brand notoriety: AORT and SRTS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AORT: 95% vs. SRTS: 78%
Market capitalization -- AORT: $985.36M vs. SRTS: $47.08M
AORT [@Medical/Nursing Services] is valued at $985.36M. SRTS’s [@Medical/Nursing Services] market capitalization is $47.08M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 1 FA rating(s) are green while SRTS’s FA Score has 1 green FA rating(s).

  • AORT’s FA Score: 1 green, 4 red.
  • SRTS’s FA Score: 1 green, 4 red.
According to our system of comparison, SRTS is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 3 TA indicator(s) are bullish while SRTS’s TA Score has 5 bullish TA indicator(s).

  • AORT’s TA Score: 3 bullish, 7 bearish.
  • SRTS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SRTS is a better buy in the short-term than AORT.

Price Growth

AORT (@Medical/Nursing Services) experienced а -24.01% price change this week, while SRTS (@Medical/Nursing Services) price change was +0.46% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

AORT is expected to report earnings on Feb 18, 2027.

SRTS is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

SRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
+3.33%
LUNG - SRTS
57%
Loosely correlated
+6.43%
HAE - SRTS
45%
Loosely correlated
-1.49%
AORT - SRTS
34%
Loosely correlated
-1.81%
GMED - SRTS
32%
Poorly correlated
+0.21%
MTD - SRTS
28%
Poorly correlated
-0.14%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GVLU29.780.13
+0.45%
Gotham 1000 Value ETF (GVLU)
AHYB44.850.12
+0.27%
American Century Select High Yield ETF (AHYB)
QIG42.670.04
+0.09%
WisdomTree U.S. Corporate Bond Fund (QIG)
GJO24.60N/A
N/A
Synthetic Fixed-Income Securities
IGOV40.10-0.18
-0.45%
iShares International Treasury Bond ETF (IGOV)